On Demand Pharmaceuticals, Inc.
Developer and operator of a distributed, modular pharmaceutical production platform designed to produce sterile injectable medicines and small-scale APIs at or near the point of care. Offers on-site and regional production services built to meet 503A/503B compounding requirements, with cGMP-ready facilities, software-driven manufacturing workflows, and AI/ML-enabled supply chain analytics to mitigate drug shortages and improve supply-chain resilience.
Industries
N/A
Products
Modular on-site medicine production platform (Pharmacy on Demand)
A modular production platform designed to produce APIs and final formulated sterile injectables at or near the point of care, integrating miniaturized continuous manufacturing, purification modules, and software-driven workflows.
Modular on-site medicine production platform (Pharmacy on Demand)
A modular production platform designed to produce APIs and final formulated sterile injectables at or near the point of care, integrating miniaturized continuous manufacturing, purification modules, and software-driven workflows.
Services
On-site and regional sterile production service (503A shortage response)
Patient-specific and anticipatory sterile compounding services designed to address immediate local drug shortages under 503A frameworks.
Turnkey 503B compounding service for health systems
cGMP-compliant production and repackaging service for larger volume needs, including access to expanded formulary updates and terminal sterilization.
AI/ML-enabled shortage mitigation and supply-chain analytics
Predictive analytics and market intelligence to identify at-risk medicines and optimize raw-material sourcing and production planning.
Emergency-response rapid production service
Rapidly deployable production capability to support medicine supply during disasters, pandemics, and other surge events.
Small-scale API production and centralized repackaging
Regional raw material and small-batch API synthesis integrated with repackaging and finished-dose manufacturing to supply distributed nodes.
On-site and regional sterile production service (503A shortage response)
Patient-specific and anticipatory sterile compounding services designed to address immediate local drug shortages under 503A frameworks.
Turnkey 503B compounding service for health systems
cGMP-compliant production and repackaging service for larger volume needs, including access to expanded formulary updates and terminal sterilization.
AI/ML-enabled shortage mitigation and supply-chain analytics
Predictive analytics and market intelligence to identify at-risk medicines and optimize raw-material sourcing and production planning.
Emergency-response rapid production service
Rapidly deployable production capability to support medicine supply during disasters, pandemics, and other surge events.
Small-scale API production and centralized repackaging
Regional raw material and small-batch API synthesis integrated with repackaging and finished-dose manufacturing to supply distributed nodes.
Expertise Areas
- Distributed pharmaceutical manufacturing
- 503A/503B compounding and sterile injectable production
- cGMP compliance and regulatory submissions
- AI/ML-driven supply chain analytics and shortage mitigation
Key Technologies
- Miniaturized continuous manufacturing
- Flow chemistry
- AI/ML-driven supply chain analytics
- Modular cleanroom and modular manufacturing units